<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.4.551">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>Penyakit Graves pada seorang perempuan dengan Sistemik Lupus Eritematosus</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
/* CSS for citations */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging-indent div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}</style>


<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script async="" src="https://hypothes.is/embed.js"></script>
<script>
  window.document.addEventListener("DOMContentLoaded", function (_event) {
    document.body.classList.add('hypothesis-enabled');
  });
</script>


<meta name="citation_title" content="Penyakit Graves pada seorang perempuan dengan Sistemik Lupus Eritematosus">
<meta name="citation_author" content="dr. Kadek Adit Wiryadana">
<meta name="citation_author" content="dr. I Made Siswadi Semadi, M.Biomed, SpPD, K-EMD">
<meta name="citation_author" content="dr. Pande Ketut Kurniari, SpPD, K-R">
<meta name="citation_language" content="en">
<meta name="citation_reference" content="citation_title=Literate programming;,citation_author=Donald E. Knuth;,citation_publication_date=1984-05;,citation_cover_date=1984-05;,citation_year=1984;,citation_fulltext_html_url=https://doi.org/10.1093/comjnl/27.2.97;,citation_issue=2;,citation_doi=10.1093/comjnl/27.2.97;,citation_issn=0010-4620;,citation_volume=27;,citation_journal_title=Comput. J.;,citation_publisher=Oxford University Press, Inc.;">
<meta name="citation_reference" content="citation_title=Graves’ disease and systemic lupus erythematosus: A mendelian randomization study;,citation_author=Wei Xian;,citation_author=Boyuan Liu;,citation_author=Jinjian Li;,citation_author=Yuxin Yang;,citation_author=Shubin Hong;,citation_author=Haipeng Xiao;,citation_author=Dide Wu;,citation_author=Yanbing Li;,citation_publication_date=2024-01-29;,citation_cover_date=2024-01-29;,citation_year=2024;,citation_fulltext_html_url=http://dx.doi.org/10.3389/fimmu.2024.1273358;,citation_doi=10.3389/fimmu.2024.1273358;,citation_volume=15;,citation_journal_title=Frontiers in Immunology;">
<meta name="citation_reference" content="citation_title=Graves’ Disease;,citation_author=Terry J. Smith;,citation_author=Laszlo Hegedüs;,citation_editor=Dan L. Longo;,citation_publication_date=2016-10-20;,citation_cover_date=2016-10-20;,citation_year=2016;,citation_fulltext_html_url=http://dx.doi.org/10.1056/NEJMra1510030;,citation_issue=16;,citation_doi=10.1056/nejmra1510030;,citation_volume=375;,citation_language=en;,citation_journal_title=New England Journal of Medicine;">
<meta name="citation_reference" content="citation_title=Graves’ disease;,citation_author=Terry F. Davies;,citation_author=Stig Andersen;,citation_author=Rauf Latif;,citation_author=Yuji Nagayama;,citation_author=Giuseppe Barbesino;,citation_author=Maria Brito;,citation_author=Anja K. Eckstein;,citation_author=Alex Stagnaro-Green;,citation_author=George J. Kahaly;,citation_publication_date=2020-07-02;,citation_cover_date=2020-07-02;,citation_year=2020;,citation_fulltext_html_url=http://dx.doi.org/10.1038/s41572-020-0184-y;,citation_issue=1;,citation_doi=10.1038/s41572-020-0184-y;,citation_volume=6;,citation_language=en;,citation_journal_title=Nature Reviews Disease Primers;">
<meta name="citation_reference" content="citation_title=The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series;,citation_author=Silvia Martina Ferrari;,citation_author=Poupak Fallahi;,citation_author=Ilaria Ruffilli;,citation_author=Giusy Elia;,citation_author=Francesca Ragusa;,citation_author=Salvatore Benvenga;,citation_author=Alessandro Antonelli;,citation_publication_date=2019-03;,citation_cover_date=2019-03;,citation_year=2019;,citation_fulltext_html_url=http://dx.doi.org/10.1016/j.autrev.2018.10.001;,citation_issue=3;,citation_doi=10.1016/j.autrev.2018.10.001;,citation_volume=18;,citation_language=en;,citation_journal_title=Autoimmunity Reviews;">
<meta name="citation_reference" content="citation_title=Association between Graves’ disease and risk of incident systemic lupus erythematosus: A nationwide population-based cohort study;,citation_author=Cho Lee;,citation_author=Shih-Fen Chen;,citation_author=Yu-Cih Yang;,citation_author=Chung Y. Hsu;,citation_author=Yu-Chih Shen;,citation_publication_date=2020-11-19;,citation_cover_date=2020-11-19;,citation_year=2020;,citation_fulltext_html_url=http://dx.doi.org/10.1111/1756-185x.14027;,citation_issue=2;,citation_doi=10.1111/1756-185x.14027;,citation_volume=24;,citation_language=en;,citation_journal_title=International Journal of Rheumatic Diseases;">
<meta name="citation_reference" content="citation_title=Association of HLA-DR3 and HLA-DR15 Polymorphisms with Risk of Systemic Lupus Erythematosus.;,citation_abstract=BACKGROUND: Systemic lupus erythematosus (SLE) is an autoimmune disease under genetic control. Growing evidences support the genetic predisposition of HLA-DRB1 gene polymorphisms to SLE, yet the results are not often reproducible. The purpose of this study was to assess the association of two polymorphisms of HLA-DRB1 gene (HLA-DR3 and HLA-DR15) with the risk of SLE via a comprehensive meta-analysis. METHODS: This study complied with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Case-control studies on HLA-DRB1 and SLE were searched from PubMed, Elsevier Science, Springer Link, Medline, and Cochrane Library database as of June 2018. Analysis was based on the random-effects model using STATA software version 14.0. RESULTS: A total of 23 studies were retained for analysis, including 5261 cases and 9838 controls. Overall analysis revealed that HLA-DR3 and HLA-DR15 polymorphisms were associated with the significant risk of SLE (odds ratio [OR]: 1.60, 95% confidence interval (CI): 1.316-1.934, P = 0.129 and OR: 1.68, 95% CI: 1.334-2.112, P = 0.001, respectively). Subgroup analyses demonstrated that for both HLA-DR3 and HLA-DR15 polymorphisms, ethnicity was a possible source of heterogeneity. Specifically, HLA-DR3 polymorphism was not associated with SLE in White populations (OR: 1.60, 95% CI: 1.320-1.960, P = 0.522) and HLA-DR15 polymorphism in East Asian populations (OR: 1.65, 95% CI: 1.248-2.173, P = 0.001). In addition, source of control was another possible source for both HLA-DR3 and HLA-DR15 polymorphisms, with observable significance for HLA-DR3 in only population-based studies (OR: 1.65, 95% CI: 1.370-1.990, P = 0.244) and for HLA-DR15 in both population-based and hospital-based studies (OR: 1.38, 95% CI: 1.078-1.760, P = 0.123 and OR: 2.08, 95% CI: 1.738-2.490, P = 0.881, respectively). CONCLUSIONS: HLA-DRB1 gene may be a SLE-susceptibility gene, and it shows evident ethnic heterogeneity. Further prospective validations across multiple ethnical groups are warranted.;,citation_author=Ke Xue;,citation_author=Wen-Quan Niu;,citation_author=Yong Cui;,citation_publication_date=2018-12;,citation_cover_date=2018-12;,citation_year=2018;,citation_issue=23;,citation_doi=10.4103/0366-6999.246058;,citation_issn=2542-5641 0366-6999;,citation_pmid=30511687;,citation_volume=131;,citation_journal_title=Chinese medical journal;">
<meta name="citation_reference" content="citation_title=De-novo and acquired resistance to immune checkpoint targeting;,citation_author=Nicholas L Syn;,citation_author=Michele W L Teng;,citation_author=Tony S K Mok;,citation_author=Ross A Soo;,citation_publication_date=2017-12;,citation_cover_date=2017-12;,citation_year=2017;,citation_fulltext_html_url=http://dx.doi.org/10.1016/s1470-2045(17)30607-1;,citation_issue=12;,citation_doi=10.1016/s1470-2045(17)30607-1;,citation_volume=18;,citation_language=en;,citation_journal_title=The Lancet Oncology;">
<meta name="citation_reference" content="citation_title=CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis;,citation_author=Jin-Xia Zhai;,citation_author=Li-Wei Zou;,citation_author=Zhao-Xiang Zhang;,citation_author=Wen-Jing Fan;,citation_author=Han-Yong Wang;,citation_author=Ting Liu;,citation_author=Zheng Ren;,citation_author=Rui-Xue Dai;,citation_author=Dongqing Ye;,citation_publication_date=2013-08-07;,citation_cover_date=2013-08-07;,citation_year=2013;,citation_fulltext_html_url=http://dx.doi.org/10.1007/s11033-012-2125-7;,citation_issue=9;,citation_doi=10.1007/s11033-012-2125-7;,citation_volume=40;,citation_language=en;,citation_journal_title=Molecular Biology Reports;">
<meta name="citation_reference" content="citation_title=Immunogenetics of autoimmune thyroid diseases: A comprehensive review;,citation_author=Hanna J. Lee;,citation_author=Cheuk Wun Li;,citation_author=Sara Salehi Hammerstad;,citation_author=Mihaela Stefan;,citation_author=Yaron Tomer;,citation_publication_date=2015-11;,citation_cover_date=2015-11;,citation_year=2015;,citation_fulltext_html_url=http://dx.doi.org/10.1016/j.jaut.2015.07.009;,citation_doi=10.1016/j.jaut.2015.07.009;,citation_volume=64;,citation_language=en;,citation_journal_title=Journal of Autoimmunity;">
<meta name="citation_reference" content="citation_title=Immunological pathogenesis and treatment of systemic lupus erythematosus;,citation_author=Lu Pan;,citation_author=Mei-Ping Lu;,citation_author=Jing-Hua Wang;,citation_author=Meng Xu;,citation_author=Si-Rui Yang;,citation_publication_date=2019-02-22;,citation_cover_date=2019-02-22;,citation_year=2019;,citation_fulltext_html_url=http://dx.doi.org/10.1007/s12519-019-00229-3;,citation_issue=1;,citation_doi=10.1007/s12519-019-00229-3;,citation_volume=16;,citation_language=en;,citation_journal_title=World Journal of Pediatrics;">
<meta name="citation_reference" content="citation_title=Regulation of type I interferon responses;,citation_author=Lionel B. Ivashkiv;,citation_author=Laura T. Donlin;,citation_publication_date=2013-12-23;,citation_cover_date=2013-12-23;,citation_year=2013;,citation_fulltext_html_url=http://dx.doi.org/10.1038/nri3581;,citation_issue=1;,citation_doi=10.1038/nri3581;,citation_volume=14;,citation_language=en;,citation_journal_title=Nature Reviews Immunology;">
<meta name="citation_reference" content="citation_title=Patients with Systemic Lupus Erythematosus Have Higher Prevalence of Thyroid Autoantibodies: A Systematic Review and Meta-Analysis;,citation_author=Xi-Feng Pan;,citation_author=Jian-Qiu Gu;,citation_author=Zhong-Yan Shan;,citation_editor=Shervin Assassi;,citation_publication_date=2015-04-23;,citation_cover_date=2015-04-23;,citation_year=2015;,citation_fulltext_html_url=http://dx.doi.org/10.1371/journal.pone.0123291;,citation_issue=4;,citation_doi=10.1371/journal.pone.0123291;,citation_volume=10;,citation_language=en;,citation_journal_title=PLOS ONE;">
<meta name="citation_reference" content="citation_title=Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy;,citation_author=G. Lanzolla;,citation_author=L. Puccinelli;,citation_author=M. Giudetti;,citation_author=S. Comi;,citation_author=F. Menconi;,citation_author=M. N. Maglionico;,citation_author=C. Posarelli;,citation_author=M. Figus;,citation_author=C. Marcocci;,citation_author=M. Marinò;,citation_publication_date=2022-08-27;,citation_cover_date=2022-08-27;,citation_year=2022;,citation_fulltext_html_url=http://dx.doi.org/10.1007/s40618-022-01906-3;,citation_issue=2;,citation_doi=10.1007/s40618-022-01906-3;,citation_volume=46;,citation_language=en;,citation_journal_title=Journal of Endocrinological Investigation;">
<meta name="citation_reference" content="citation_title=Graves’ disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy;,citation_author=Alessandro Antonelli;,citation_author=Poupak Fallahi;,citation_author=Giusy Elia;,citation_author=Francesca Ragusa;,citation_author=Sabrina Rosaria Paparo;,citation_author=Ilaria Ruffilli;,citation_author=Armando Patrizio;,citation_author=Debora Gonnella;,citation_author=Claudia Giusti;,citation_author=Camilla Virili;,citation_author=Marco Centanni;,citation_author=Yehuda Shoenfeld;,citation_author=Silvia Martina Ferrari;,citation_publication_date=2020-01;,citation_cover_date=2020-01;,citation_year=2020;,citation_fulltext_html_url=http://dx.doi.org/10.1016/j.beem.2020.101388;,citation_issue=1;,citation_doi=10.1016/j.beem.2020.101388;,citation_volume=34;,citation_language=en;,citation_journal_title=Best Practice &amp;amp;amp; Research Clinical Endocrinology &amp; Metabolism;">
<meta name="citation_reference" content="citation_title=Chemokine (CXC motif) ligand (CXCL)10 in autoimmune diseases;,citation_author=Alessandro Antonelli;,citation_author=Silvia Martina Ferrari;,citation_author=Dilia Giuggioli;,citation_author=Ele Ferrannini;,citation_author=Clodoveo Ferri;,citation_author=Poupak Fallahi;,citation_publication_date=2014-03;,citation_cover_date=2014-03;,citation_year=2014;,citation_fulltext_html_url=http://dx.doi.org/10.1016/j.autrev.2013.10.010;,citation_issue=3;,citation_doi=10.1016/j.autrev.2013.10.010;,citation_volume=13;,citation_language=en;,citation_journal_title=Autoimmunity Reviews;">
<meta name="citation_reference" content="citation_title=Insights into IL-37, the role in autoimmune diseases;,citation_author=Wang-Dong Xu;,citation_author=Yi Zhao;,citation_author=Yi Liu;,citation_publication_date=2015-12;,citation_cover_date=2015-12;,citation_year=2015;,citation_fulltext_html_url=http://dx.doi.org/10.1016/j.autrev.2015.08.006;,citation_issue=12;,citation_doi=10.1016/j.autrev.2015.08.006;,citation_volume=14;,citation_language=en;,citation_journal_title=Autoimmunity Reviews;">
<meta name="citation_reference" content="">
</head>

<body>

<header id="title-block-header" class="quarto-title-block default toc-left page-columns page-full">
  <div class="quarto-title-banner page-columns page-full">
    <div class="quarto-title column-body">
      <h1 class="title">Penyakit Graves pada seorang perempuan dengan Sistemik Lupus Eritematosus</h1>
          </div>

    
    <div class="quarto-title-meta-container">
      <div class="quarto-title-meta-column-start">
            <div class="quarto-title-meta-author">
          <div class="quarto-title-meta-heading">Authors</div>
          <div class="quarto-title-meta-heading">Affiliation</div>
          
                <div class="quarto-title-meta-contents">
            <p class="author">dr. Kadek Adit Wiryadana </p>
          </div>
                <div class="quarto-title-meta-contents">
                    <p class="affiliation">
                        Universitas Udayana
                      </p>
                  </div>
                      <div class="quarto-title-meta-contents">
            <p class="author">dr. I Made Siswadi Semadi, M.Biomed, SpPD, K-EMD </p>
          </div>
                <div class="quarto-title-meta-contents">
                    <p class="affiliation">
                        Universitas Udayana
                      </p>
                  </div>
                      <div class="quarto-title-meta-contents">
            <p class="author">dr. Pande Ketut Kurniari, SpPD, K-R </p>
          </div>
                <div class="quarto-title-meta-contents">
                    <p class="affiliation">
                        Universitas Udayana
                      </p>
                  </div>
                    </div>
        
        <div class="quarto-title-meta">

                      
          
                
              </div>
      </div>
      <div class="quarto-title-meta-column-end quarto-other-formats-target">
      <div class="quarto-alternate-formats"><div class="quarto-title-meta-heading">Other Formats</div><div class="quarto-title-meta-contents"><p><a href="index.docx"><i class="bi bi-file-word"></i>MS Word</a></p></div><div class="quarto-title-meta-contents"><p><a href="index.pdf"><i class="bi bi-file-pdf"></i>PDF (plos)</a></p></div><div class="quarto-title-meta-contents"><p><a href="index-meca.zip" data-meca-link="true"><i class="bi bi-archive"></i>MECA Bundle</a></p></div></div></div>
    </div>



    <div class="quarto-other-links-text-target">
    </div>  </div>
</header><div id="quarto-content" class="page-columns page-rows-contents page-layout-article toc-left">
<div id="quarto-sidebar-toc-left" class="sidebar toc-left">
  <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">Table of contents</h2>
   
  <ul>
  <li><a href="#abstrak" id="toc-abstrak" class="nav-link active" data-scroll-target="#abstrak">Abstrak</a></li>
  <li><a href="#pendahuluan" id="toc-pendahuluan" class="nav-link" data-scroll-target="#pendahuluan">Pendahuluan</a></li>
  <li><a href="#laporan-kasus" id="toc-laporan-kasus" class="nav-link" data-scroll-target="#laporan-kasus">Laporan Kasus</a></li>
  <li><a href="#diskusi" id="toc-diskusi" class="nav-link" data-scroll-target="#diskusi">Diskusi</a></li>
  <li><a href="#ringkasan" id="toc-ringkasan" class="nav-link" data-scroll-target="#ringkasan">Ringkasan</a></li>
  <li><a href="#daftar-pustaka" id="toc-daftar-pustaka" class="nav-link" data-scroll-target="#daftar-pustaka">Daftar Pustaka</a></li>
  </ul>
</nav>
</div>
<div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
</div>
<main class="content quarto-banner-title-block" id="quarto-document-content">



  


<section id="abstrak" class="level2">
<h2 class="anchored" data-anchor-id="abstrak">Abstrak</h2>
</section>
<section id="pendahuluan" class="level2">
<h2 class="anchored" data-anchor-id="pendahuluan">Pendahuluan</h2>
<p>Koinsidensi penyakit graves dan sistemik lupus eritematosus (SLE) belakangan ini mendapat perhatian lebih karena ditemukan memiliki hubungan yang tidak sekedar sesuatu yang terjadi secara acak. Hubungan kausal antara kedua entitas penyakit automimun tersebut masih belum banyak diketahui dan saat ini masih terdapat berbagai penelitian yang mendalami hal tersebut.<span class="citation" data-cites="xian2024"><sup><a href="#ref-xian2024" role="doc-biblioref">1</a></sup></span> Penyakit graves merupakan salah satu penyakit autoimun pada organ endokrin thyroid dan merupakan penyebab utama hipertiroidisme.<span class="citation" data-cites="smith2016"><sup><a href="#ref-smith2016" role="doc-biblioref">2</a></sup></span> Insiden enyakit Graves sebagai penyakit autoimun termasuk cukup tinggi dengan rentang 20 - 50 kasus per 100.000 individual serta tingkat prevalensi diperkirakan 1 - 1.5%.<span class="citation" data-cites="davies2020"><sup><a href="#ref-davies2020" role="doc-biblioref">3</a></sup></span> Penyakit graves memilki target organ khusus, namun koinsidensi dengan penyakit autoimun lain seperti SLE, Rheumatoid arthritis, multiple sclerosis, diabetes tipe 1 dan lainnya diperkirakan sekitar 16.7% dari total pasien dengan penyakit graves. Data lebih lanjut dari laporan serial kasus terbaru. juga menunjukan bahwa persentase pasien dengan penyakit Graves juga ditemukan memiliki 3 penyakit autoimun lain sebesar 1.5%.<span class="citation" data-cites="ferrari2019"><sup><a href="#ref-ferrari2019" role="doc-biblioref">4</a></sup></span></p>
<p>SLE merupakan penyakit yang memiliki variasi spektrum klinis yang luas akibat terget organ multipel dan heterogen. Penelitian kohort multisenter di China menemukan bahwa individu dengan penyakit graves lebih rentan mengalami SLE dibanding individu kontrol yang sehat.<span class="citation" data-cites="lee2020"><sup><a href="#ref-lee2020" role="doc-biblioref">5</a></sup></span> Penelitian terbaru dari Xian et al dengan analisis randomisasi mendelian menemukan bahwa terdapat korelasi antara penyakit graves dan SLE, dan masing-masing entitas autoimun tersebut saling mendukung untuk koinsidensi autoimun lainnya. Temuan-temuan ini memberikan gambaran bahwa pada praktik klinis diharapkan klinisi dapat meningkatkan skrining penyakit autoimun khususnya penyakit graves atau SLE saat menegakan diagnosis salah satu penyakit autoimun tersebut.<span class="citation" data-cites="xian2024"><sup><a href="#ref-xian2024" role="doc-biblioref">1</a></sup></span> Laporan kasus ini memaparkan seorang pasien perempuan dengan krisis tiroid akibat penyakit graves yang sebelumnya diketahui memiliki penyakit SLE.</p>
</section>
<section id="laporan-kasus" class="level2">
<h2 class="anchored" data-anchor-id="laporan-kasus">Laporan Kasus</h2>
</section>
<section id="diskusi" class="level2">
<h2 class="anchored" data-anchor-id="diskusi">Diskusi</h2>
<p>Penelitian terbaru oleh Xian et al menemukan bahwa SLE meningkatkan risiko penyaki graves (OR=1.13, 95% CI 1.05-1.22, p =0.003), dan berlaku juga sebaliknya penyakit graves meningkatkan risiko SLE (OR=1.27, 95% CI 1.09-1.48, p =0.018).<span class="citation" data-cites="xian2024"><sup><a href="#ref-xian2024" role="doc-biblioref">1</a></sup></span> Hubungan sebab akibat antara penyakit graves dan SLE yang ditemukan dalam penelitian tersebut semakin menegaskan temuan epidemiologi sebelumnya. Patogenesis SLE dan penyakit graves mungkin dipengaruhi oleh mutasi pada gen HLA. Sebuah meta-analisis yang dilakukan sebelumnya menemukan bahwa mutasi pada HLA-DR3 dan HLA-DR15 secara signifikan meningkatkan kemungkinan SLE.<span class="citation" data-cites="xue_2018"><sup><a href="#ref-xue_2018" role="doc-biblioref">6</a></sup></span> Kehadiran gen HLA yang bermutasi dapat mengakibatkan perubahan kompleks HLA pada sel penyaji antigen, sehingga mempengaruhi interaksi antara sel B dan T. Situasi ini dapat menyebabkan disregulasi sel B yang reaktif terhadap diri sendiri dan produksi autoantibodi, yang dapat berfungsi sebagai mediator efek kausal SLE pada penyakit graves.[<span class="citation" data-cites="xian2024"><sup><a href="#ref-xian2024" role="doc-biblioref">1</a></sup></span>]</p>
<p>Selain gen terkait HLA, gen non-HLA juga diduga memainkan peran penting dalam interaksi antara SLE dan penyakit graves. Protein terkait limfosit T sitotoksik 4 (CTLA-4) adalah reseptor protein yang berfungsi sebagai cek poin pemeriksaan imun untuk menurunkan regulasi respons imun dengan mengikat ligan CD80 dan CD86 pada permukaan sel penyaji antigen, sehingga mengatur aktivasi sel T dan proliferasinya.<span class="citation" data-cites="syn2017"><sup><a href="#ref-syn2017" role="doc-biblioref">7</a></sup></span> Mutasi pada gen CTLA-4 telah dikaitkan dengan SLE dan penyakit graves. Sebuah meta-analisis menunjukkan bahwa polimorfisme gen CTLA-4 pada populasi Asia dikaitkan dengan risiko SLE.<span class="citation" data-cites="zhai2013"><sup><a href="#ref-zhai2013" role="doc-biblioref">8</a></sup></span> Sebuah studi oleh Lee dkk. menemukan bahwa beberapa polimorfisme nukleotida tunggal CTLA-4 dikaitkan dengan penyakit graves dan penyakit tiroid autoimun seperti tiroiditis Hashimoto.<span class="citation" data-cites="lee2015"><sup><a href="#ref-lee2015" role="doc-biblioref">9</a></sup></span> Mutasi pada gen CTLA-4 dapat menyebabkan defisiensi regulasi penurunan regulasi respon imun sel T, yang mengakibatkan hiperaktivasi sel T dan dengan demikian memicu penyakit autoimun. Faktor ini mungkin juga memainkan peran mediasi dalam hubungan antara penyakit graves dan SLE.<span class="citation" data-cites="xian2024"><sup><a href="#ref-xian2024" role="doc-biblioref">1</a></sup></span></p>
<p>SLE dan penyakit graves ditandai oleh kelainan regulasi imun yang mungkin berhubungan erat dengan interferon tipe I (IFN-I).<span class="citation" data-cites="pan2019"><sup><a href="#ref-pan2019" role="doc-biblioref">10</a></sup></span> Interferon tipe I, termasuk IFN-a, IFN-b, IFN-ϵ, IFN-k, dll., adalah sitokin yang memainkan peran penting dalam peradangan, regulasi kekebalan, pengenalan sel tumor, dan respons sel T. Dalam konteks penyakit autoimun, IFN-I dapat berkontribusi pada perkembangan SLE dengan meningkatkan presentasi antigen dan respon limfosit serta menginduksi ekspresi kemokin. IFN-I meningkatkan aktivasi sel B, diferensiasi, proliferasi dan produksi antibodi, dan dapat menginduksi ekspresi reseptor <em>Thyroid-timulating hormone</em>.<span class="citation" data-cites="ivashkiv2013"><sup><a href="#ref-ivashkiv2013" role="doc-biblioref">11</a></sup></span> Dengan demikian, hal ini mungkin berdampak pada menignkatnya risiko penyakit graves.</p>
<p>Selain regulasi imun yang menyimpang, SLE dan penyakit graves mungkin memiliki patogenesis yang sama terkait autoantibodi yang menyebabkan kerusakan jaringan. Sebuah meta-analisis yang dilakukan oleh Pan et al.&nbsp;menunjukkan bahwa kadar antibodi tiroid peroksidase (TPOAb) dan antibodi tiroglobulin (TgAb) jauh lebih tinggi pada pasien SLE dibandingkan dengan populasi sehat, yang menunjukkan adanya korelasi antara SLE dan penyakit tiroid autoimun.<span class="citation" data-cites="pan2015"><sup><a href="#ref-pan2015" role="doc-biblioref">12</a></sup></span> Penelitian yang dilakukan oleh Lanzolla dkk. menunjukkan bahwa keberadaan antibodi antinuklear diamati pada sekitar 80% pasien yang didiagnosis dengan penyakit graves. Temuan ini menunjukkan bahwa penyakit graves berpotensi mempengaruhi perkembangan SLE melalui jalur autoantibodi.<span class="citation" data-cites="lanzolla2022"><sup><a href="#ref-lanzolla2022" role="doc-biblioref">13</a></sup></span></p>
<p>Jalur imunologi yang sama dalam perkembangan SLE dan penyakit graves ditunjukkan oleh adanya tumpang tindih kemokin dan sitokin spesifik. Penelitian terbaru berfokus pada interaksi antara CXCL10 dan CXCR3 dalam respon imun T helper 1 sangat penting dalam etiologi penyakit graves dan SLE.<span class="citation" data-cites="antonelli2014 antonelli2020"><sup><a href="#ref-antonelli2014" role="doc-biblioref">14</a>,<a href="#ref-antonelli2020" role="doc-biblioref">15</a></sup></span> Selain itu, dilaporkan bahwa peningkatan kadar IL-37 berkorelasi positif dengan konsentrasi TRAb dan derajat aktivitas SLE, sehingga ini menunjukkan bahwa IL-37 memainkan peran penting dalam terjadinya penyakit graves dan SLE.<span class="citation" data-cites="xu2015"><sup><a href="#ref-xu2015" role="doc-biblioref">16</a></sup></span></p>
</section>
<section id="ringkasan" class="level2">
<h2 class="anchored" data-anchor-id="ringkasan">Ringkasan</h2>
<p>Penyakit Graves secara genetik diprediksi meningkatkan risiko SLE, dan berlaku juga sebaliknya. Laporan kasus ini diharapkan dapat memberikan dasar baru untuk skrining dan tatalaksana pasien dengan penyakit graves yang memiliki gejala baru yang tidak spesifik harus diskrining untuk SLE sehingga memfasilitasi diagnosis dan pengobatan tepat waktu dan menghindari penundaan atau eksaserbasi penyakit. Pada saat yang sama, fungsi tiroid juga perlu dipantau selama penatalaksanaan pasien SLE, sehingga dapat menyesuaikan rencana pengobatan dan menjamin kualitas hidup pasien.</p>
</section>
<section id="daftar-pustaka" class="level2 unnumbered">


</section>

<div id="quarto-appendix" class="default"><section class="quarto-appendix-contents" role="doc-bibliography" id="quarto-bibliography"><h2 class="anchored quarto-appendix-heading">Daftar Pustaka</h2><div id="refs" class="references csl-bib-body" role="list">
<div id="ref-xian2024" class="csl-entry" role="listitem">
<div class="csl-left-margin">1. </div><div class="csl-right-inline">Xian W, Liu B, Li J, Yang Y, Hong S, Xiao H, et al. Graves<span>’</span> disease and systemic lupus erythematosus: A mendelian randomization study. Frontiers in Immunology. 2024;15. Diakses pada: <a href="http://dx.doi.org/10.3389/fimmu.2024.1273358">http://dx.doi.org/10.3389/fimmu.2024.1273358</a></div>
</div>
<div id="ref-smith2016" class="csl-entry" role="listitem">
<div class="csl-left-margin">2. </div><div class="csl-right-inline">Smith TJ, Hegedüs L. Graves<span>’</span> Disease. Longo DL, editor. New England Journal of Medicine. 2016;375(16):1552–65. Diakses pada: <a href="http://dx.doi.org/10.1056/NEJMra1510030">http://dx.doi.org/10.1056/NEJMra1510030</a></div>
</div>
<div id="ref-davies2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">3. </div><div class="csl-right-inline">Davies TF, Andersen S, Latif R, Nagayama Y, Barbesino G, Brito M, et al. Graves<span>’</span> disease. Nature Reviews Disease Primers. 2020;6(1). Diakses pada: <a href="http://dx.doi.org/10.1038/s41572-020-0184-y">http://dx.doi.org/10.1038/s41572-020-0184-y</a></div>
</div>
<div id="ref-ferrari2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">4. </div><div class="csl-right-inline">Ferrari SM, Fallahi P, Ruffilli I, Elia G, Ragusa F, Benvenga S, et al. The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series. Autoimmunity Reviews. 2019;18(3):287–92. Diakses pada: <a href="http://dx.doi.org/10.1016/j.autrev.2018.10.001">http://dx.doi.org/10.1016/j.autrev.2018.10.001</a></div>
</div>
<div id="ref-lee2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">5. </div><div class="csl-right-inline">Lee C, Chen S-F, Yang Y-C, Hsu CY, Shen Y-C. Association between Graves’ disease and risk of incident systemic lupus erythematosus: A nationwide population<span>-</span>based cohort study. International Journal of Rheumatic Diseases. 2020;24(2):240–5. Diakses pada: <a href="http://dx.doi.org/10.1111/1756-185x.14027">http://dx.doi.org/10.1111/1756-185x.14027</a></div>
</div>
<div id="ref-xue_2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">6. </div><div class="csl-right-inline">Xue K, Niu W-Q, Cui Y. <a href="https://doi.org/10.4103/0366-6999.246058">Association of <span>HLA</span>-<span>DR3</span> and <span>HLA</span>-<span>DR15</span> <span>Polymorphisms</span> with <span>Risk</span> of <span>Systemic</span> <span>Lupus</span> <span>Erythematosus</span>.</a> Chinese medical journal. 2018;131(23):2844–51. </div>
</div>
<div id="ref-syn2017" class="csl-entry" role="listitem">
<div class="csl-left-margin">7. </div><div class="csl-right-inline">Syn NL, Teng MWL, Mok TSK, Soo RA. De-novo and acquired resistance to immune checkpoint targeting. The Lancet Oncology. 2017;18(12):e731–41. Diakses pada: <a href="http://dx.doi.org/10.1016/s1470-2045(17)30607-1">http://dx.doi.org/10.1016/s1470-2045(17)30607-1</a></div>
</div>
<div id="ref-zhai2013" class="csl-entry" role="listitem">
<div class="csl-left-margin">8. </div><div class="csl-right-inline">Zhai J-X, Zou L-W, Zhang Z-X, Fan W-J, Wang H-Y, Liu T, et al. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Molecular Biology Reports. 2013;40(9):5213–23. Diakses pada: <a href="http://dx.doi.org/10.1007/s11033-012-2125-7">http://dx.doi.org/10.1007/s11033-012-2125-7</a></div>
</div>
<div id="ref-lee2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">9. </div><div class="csl-right-inline">Lee HJ, Li CW, Hammerstad SS, Stefan M, Tomer Y. Immunogenetics of autoimmune thyroid diseases: A comprehensive review. Journal of Autoimmunity. 2015;64:82–90. Diakses pada: <a href="http://dx.doi.org/10.1016/j.jaut.2015.07.009">http://dx.doi.org/10.1016/j.jaut.2015.07.009</a></div>
</div>
<div id="ref-pan2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">10. </div><div class="csl-right-inline">Pan L, Lu M-P, Wang J-H, Xu M, Yang S-R. Immunological pathogenesis and treatment of systemic lupus erythematosus. World Journal of Pediatrics. 2019;16(1):19–30. Diakses pada: <a href="http://dx.doi.org/10.1007/s12519-019-00229-3">http://dx.doi.org/10.1007/s12519-019-00229-3</a></div>
</div>
<div id="ref-ivashkiv2013" class="csl-entry" role="listitem">
<div class="csl-left-margin">11. </div><div class="csl-right-inline">Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nature Reviews Immunology. 2013;14(1):36–49. Diakses pada: <a href="http://dx.doi.org/10.1038/nri3581">http://dx.doi.org/10.1038/nri3581</a></div>
</div>
<div id="ref-pan2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">12. </div><div class="csl-right-inline">Pan X-F, Gu J-Q, Shan Z-Y. Patients with Systemic Lupus Erythematosus Have Higher Prevalence of Thyroid Autoantibodies: A Systematic Review and Meta-Analysis. Assassi S, editor. PLOS ONE. 2015;10(4):e0123291. Diakses pada: <a href="http://dx.doi.org/10.1371/journal.pone.0123291">http://dx.doi.org/10.1371/journal.pone.0123291</a></div>
</div>
<div id="ref-lanzolla2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">13. </div><div class="csl-right-inline">Lanzolla G, Puccinelli L, Giudetti M, Comi S, Menconi F, Maglionico MN, et al. Anti-nuclear autoantibodies in Graves<span>’</span> disease and Graves<span>’</span> orbitopathy. Journal of Endocrinological Investigation. 2022;46(2):337–44. Diakses pada: <a href="http://dx.doi.org/10.1007/s40618-022-01906-3">http://dx.doi.org/10.1007/s40618-022-01906-3</a></div>
</div>
<div id="ref-antonelli2014" class="csl-entry" role="listitem">
<div class="csl-left-margin">14. </div><div class="csl-right-inline">Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P. Chemokine (C<span></span>X<span></span>C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmunity Reviews. 2014;13(3):272–80. Diakses pada: <a href="http://dx.doi.org/10.1016/j.autrev.2013.10.010">http://dx.doi.org/10.1016/j.autrev.2013.10.010</a></div>
</div>
<div id="ref-antonelli2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">15. </div><div class="csl-right-inline">Antonelli A, Fallahi P, Elia G, Ragusa F, Paparo SR, Ruffilli I, et al. Graves’ disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism. 2020;34(1):101388. Diakses pada: <a href="http://dx.doi.org/10.1016/j.beem.2020.101388">http://dx.doi.org/10.1016/j.beem.2020.101388</a></div>
</div>
<div id="ref-xu2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">16. </div><div class="csl-right-inline">Xu W-D, Zhao Y, Liu Y. Insights into IL-37, the role in autoimmune diseases. Autoimmunity Reviews. 2015;14(12):1170–5. Diakses pada: <a href="http://dx.doi.org/10.1016/j.autrev.2015.08.006">http://dx.doi.org/10.1016/j.autrev.2015.08.006</a></div>
</div>
</div></section></div></main>
<!-- /main column -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    text: function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
    var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
    var mailtoRegex = new RegExp(/^mailto:/);
      var filterRegex = new RegExp('/' + window.location.host + '/');
    var isInternal = (href) => {
        return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
    }
    // Inspect non-navigation links and adorn them if external
 	var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool)');
    for (var i=0; i<links.length; i++) {
      const link = links[i];
      if (!isInternal(link.href)) {
        // undo the damage that might have been done by quarto-nav.js in the case of
        // links that we want to consider external
        if (link.dataset.originalHref !== undefined) {
          link.href = link.dataset.originalHref;
        }
      }
    }
  function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
    const config = {
      allowHTML: true,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start',
    };
    if (contentFn) {
      config.content = contentFn;
    }
    if (onTriggerFn) {
      config.onTrigger = onTriggerFn;
    }
    if (onUntriggerFn) {
      config.onUntrigger = onUntriggerFn;
    }
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      if (note) {
        return note.innerHTML;
      } else {
        return "";
      }
    });
  }
  const xrefs = window.document.querySelectorAll('a.quarto-xref');
  const processXRef = (id, note) => {
    // Strip column container classes
    const stripColumnClz = (el) => {
      el.classList.remove("page-full", "page-columns");
      if (el.children) {
        for (const child of el.children) {
          stripColumnClz(child);
        }
      }
    }
    stripColumnClz(note)
    if (id === null || id.startsWith('sec-')) {
      // Special case sections, only their first couple elements
      const container = document.createElement("div");
      if (note.children && note.children.length > 2) {
        container.appendChild(note.children[0].cloneNode(true));
        for (let i = 1; i < note.children.length; i++) {
          const child = note.children[i];
          if (child.tagName === "P" && child.innerText === "") {
            continue;
          } else {
            container.appendChild(child.cloneNode(true));
            break;
          }
        }
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(container);
        }
        return container.innerHTML
      } else {
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(note);
        }
        return note.innerHTML;
      }
    } else {
      // Remove any anchor links if they are present
      const anchorLink = note.querySelector('a.anchorjs-link');
      if (anchorLink) {
        anchorLink.remove();
      }
      if (window.Quarto?.typesetMath) {
        window.Quarto.typesetMath(note);
      }
      // TODO in 1.5, we should make sure this works without a callout special case
      if (note.classList.contains("callout")) {
        return note.outerHTML;
      } else {
        return note.innerHTML;
      }
    }
  }
  for (var i=0; i<xrefs.length; i++) {
    const xref = xrefs[i];
    tippyHover(xref, undefined, function(instance) {
      instance.disable();
      let url = xref.getAttribute('href');
      let hash = undefined; 
      if (url.startsWith('#')) {
        hash = url;
      } else {
        try { hash = new URL(url).hash; } catch {}
      }
      if (hash) {
        const id = hash.replace(/^#\/?/, "");
        const note = window.document.getElementById(id);
        if (note !== null) {
          try {
            const html = processXRef(id, note.cloneNode(true));
            instance.setContent(html);
          } finally {
            instance.enable();
            instance.show();
          }
        } else {
          // See if we can fetch this
          fetch(url.split('#')[0])
          .then(res => res.text())
          .then(html => {
            const parser = new DOMParser();
            const htmlDoc = parser.parseFromString(html, "text/html");
            const note = htmlDoc.getElementById(id);
            if (note !== null) {
              const html = processXRef(id, note);
              instance.setContent(html);
            } 
          }).finally(() => {
            instance.enable();
            instance.show();
          });
        }
      } else {
        // See if we can fetch a full url (with no hash to target)
        // This is a special case and we should probably do some content thinning / targeting
        fetch(url)
        .then(res => res.text())
        .then(html => {
          const parser = new DOMParser();
          const htmlDoc = parser.parseFromString(html, "text/html");
          const note = htmlDoc.querySelector('main.content');
          if (note !== null) {
            // This should only happen for chapter cross references
            // (since there is no id in the URL)
            // remove the first header
            if (note.children.length > 0 && note.children[0].tagName === "HEADER") {
              note.children[0].remove();
            }
            const html = processXRef(null, note);
            instance.setContent(html);
          } 
        }).finally(() => {
          instance.enable();
          instance.show();
        });
      }
    }, function(instance) {
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            div.style.left = 0;
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
        // Handle positioning of the toggle
    window.addEventListener(
      "resize",
      throttle(() => {
        elRect = undefined;
        if (selectedAnnoteEl) {
          selectCodeLines(selectedAnnoteEl);
        }
      }, 10)
    );
    function throttle(fn, ms) {
    let throttle = false;
    let timer;
      return (...args) => {
        if(!throttle) { // first call gets through
            fn.apply(this, args);
            throttle = true;
        } else { // all the others get throttled
            if(timer) clearTimeout(timer); // cancel #2
            timer = setTimeout(() => {
              fn.apply(this, args);
              timer = throttle = false;
            }, ms);
        }
      };
    }
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
</div> <!-- /content -->




</body></html>